Status:
COMPLETED
A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to estimate the number of patients with cardiovascular disease and risk factors in patients who had been diagnosed with type 2 diabetes mellitus. Simultaneously, this study also intend...
Eligibility Criteria
Inclusion
- Main study population (Data collection - Prevalence):
- Signed Informed Consent Form (ICF) obtained before any study-related activities (study-related activities are any procedures related to recording of data according to protocol)
- Male or female patient, age greater or equal to 18 years at the time of signing ICF
- Patients diagnosed with type 2 diabetes
- Subgroup (Data collection - Patient management):
- Patients followed at the hospital setting by the endocrinologist or internal medicine specialist (ambulatory diabetes management) and with available medical records, retrospectively within the last three years
- Patients with type 2 diabetes mellitus and established cardiovascular disease diagnosed at least three years ago
Exclusion
- Previous participation in this study. Participation is defined as signed ICF
- Female patient who is pregnant or breast-feeding
- Patients with type 1 diabetes
- Participation in a clinical trial within the last 3 years
Key Trial Info
Start Date :
January 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2019
Estimated Enrollment :
730 Patients enrolled
Trial Details
Trial ID
NCT03797885
Start Date
January 15 2019
End Date
October 15 2019
Last Update
November 20 2020
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Almada, Portugal, 2805-267
2
Novo Nordisk Investigational Site
Caldas da Rainha, Portugal, 2500-176
3
Novo Nordisk Investigational Site
Leiria, Portugal, 2410-197
4
Novo Nordisk Investigational Site
Lisbon, Portugal, 1349-019